Brain Cancer Treatment Market, Global Outlook and Forecast 2022-2028

April 2022 | 60 pages | ID: B9390D132AE2EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Brain Cancer Treatment in Global, including the following market information:

Global Brain Cancer Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Brain Cancer Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Chemotherapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Brain Cancer Treatment include Novartis AG, F. Hoffmann-La Roche Ltd, Pfizer,Inc, Y-mAbs Therapeutics,Inc, Merck & Co.Inc, Johnson & Johnson, AstraZeneca, Bristol-Myers Squibb and Amgen Inc and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Brain Cancer Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Brain Cancer Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Brain Cancer Treatment Market Segment Percentages, by Type, 2021 (%)

• Chemotherapy
• Immunotherapy
• Targeted Therapy
• Others

Global Brain Cancer Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Brain Cancer Treatment Market Segment Percentages, by Application, 2021 (%)

• Primary Brain Cancer
• Secondary Brain Cancer

Global Brain Cancer Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Brain Cancer Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Brain Cancer Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Brain Cancer Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Novartis AG
• F. Hoffmann-La Roche Ltd
• Pfizer,Inc
• Y-mAbs Therapeutics,Inc
• Merck & Co.Inc
• Johnson & Johnson
• AstraZeneca
• Bristol-Myers Squibb
• Amgen Inc
• GlaxoSmith Kline PLC

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Brain Cancer Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Brain Cancer Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL BRAIN CANCER TREATMENT OVERALL MARKET SIZE

2.1 Global Brain Cancer Treatment Market Size: 2021 VS 2028
2.2 Global Brain Cancer Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Brain Cancer Treatment Players in Global Market
3.2 Top Global Brain Cancer Treatment Companies Ranked by Revenue
3.3 Global Brain Cancer Treatment Revenue by Companies
3.4 Top 3 and Top 5 Brain Cancer Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Brain Cancer Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Brain Cancer Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Brain Cancer Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Brain Cancer Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Brain Cancer Treatment Market Size Markets, 2021 & 2028
  4.1.2 Chemotherapy
  4.1.3 Immunotherapy
  4.1.4 Targeted Therapy
  4.1.5 Others
4.2 By Type - Global Brain Cancer Treatment Revenue & Forecasts
  4.2.1 By Type - Global Brain Cancer Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Brain Cancer Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Brain Cancer Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Brain Cancer Treatment Market Size, 2021 & 2028
  5.1.2 Primary Brain Cancer
  5.1.3 Secondary Brain Cancer
5.2 By Application - Global Brain Cancer Treatment Revenue & Forecasts
  5.2.1 By Application - Global Brain Cancer Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Brain Cancer Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Brain Cancer Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Brain Cancer Treatment Market Size, 2021 & 2028
6.2 By Region - Global Brain Cancer Treatment Revenue & Forecasts
  6.2.1 By Region - Global Brain Cancer Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Brain Cancer Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Brain Cancer Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Brain Cancer Treatment Revenue, 2017-2028
  6.3.2 US Brain Cancer Treatment Market Size, 2017-2028
  6.3.3 Canada Brain Cancer Treatment Market Size, 2017-2028
  6.3.4 Mexico Brain Cancer Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Brain Cancer Treatment Revenue, 2017-2028
  6.4.2 Germany Brain Cancer Treatment Market Size, 2017-2028
  6.4.3 France Brain Cancer Treatment Market Size, 2017-2028
  6.4.4 U.K. Brain Cancer Treatment Market Size, 2017-2028
  6.4.5 Italy Brain Cancer Treatment Market Size, 2017-2028
  6.4.6 Russia Brain Cancer Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Brain Cancer Treatment Market Size, 2017-2028
  6.4.8 Benelux Brain Cancer Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Brain Cancer Treatment Revenue, 2017-2028
  6.5.2 China Brain Cancer Treatment Market Size, 2017-2028
  6.5.3 Japan Brain Cancer Treatment Market Size, 2017-2028
  6.5.4 South Korea Brain Cancer Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Brain Cancer Treatment Market Size, 2017-2028
  6.5.6 India Brain Cancer Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Brain Cancer Treatment Revenue, 2017-2028
  6.6.2 Brazil Brain Cancer Treatment Market Size, 2017-2028
  6.6.3 Argentina Brain Cancer Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Brain Cancer Treatment Revenue, 2017-2028
  6.7.2 Turkey Brain Cancer Treatment Market Size, 2017-2028
  6.7.3 Israel Brain Cancer Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Brain Cancer Treatment Market Size, 2017-2028
  6.7.5 UAE Brain Cancer Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Novartis AG
  7.1.1 Novartis AG Corporate Summary
  7.1.2 Novartis AG Business Overview
  7.1.3 Novartis AG Brain Cancer Treatment Major Product Offerings
  7.1.4 Novartis AG Brain Cancer Treatment Revenue in Global Market (2017-2022)
  7.1.5 Novartis AG Key News
7.2 F. Hoffmann-La Roche Ltd
  7.2.1 F. Hoffmann-La Roche Ltd Corporate Summary
  7.2.2 F. Hoffmann-La Roche Ltd Business Overview
  7.2.3 F. Hoffmann-La Roche Ltd Brain Cancer Treatment Major Product Offerings
  7.2.4 F. Hoffmann-La Roche Ltd Brain Cancer Treatment Revenue in Global Market (2017-2022)
  7.2.5 F. Hoffmann-La Roche Ltd Key News
7.3 Pfizer,Inc
  7.3.1 Pfizer,Inc Corporate Summary
  7.3.2 Pfizer,Inc Business Overview
  7.3.3 Pfizer,Inc Brain Cancer Treatment Major Product Offerings
  7.3.4 Pfizer,Inc Brain Cancer Treatment Revenue in Global Market (2017-2022)
  7.3.5 Pfizer,Inc Key News
7.4 Y-mAbs Therapeutics,Inc
  7.4.1 Y-mAbs Therapeutics,Inc Corporate Summary
  7.4.2 Y-mAbs Therapeutics,Inc Business Overview
  7.4.3 Y-mAbs Therapeutics,Inc Brain Cancer Treatment Major Product Offerings
  7.4.4 Y-mAbs Therapeutics,Inc Brain Cancer Treatment Revenue in Global Market (2017-2022)
  7.4.5 Y-mAbs Therapeutics,Inc Key News
7.5 Merck & Co.Inc
  7.5.1 Merck & Co.Inc Corporate Summary
  7.5.2 Merck & Co.Inc Business Overview
  7.5.3 Merck & Co.Inc Brain Cancer Treatment Major Product Offerings
  7.5.4 Merck & Co.Inc Brain Cancer Treatment Revenue in Global Market (2017-2022)
  7.5.5 Merck & Co.Inc Key News
7.6 Johnson & Johnson
  7.6.1 Johnson & Johnson Corporate Summary
  7.6.2 Johnson & Johnson Business Overview
  7.6.3 Johnson & Johnson Brain Cancer Treatment Major Product Offerings
  7.6.4 Johnson & Johnson Brain Cancer Treatment Revenue in Global Market (2017-2022)
  7.6.5 Johnson & Johnson Key News
7.7 AstraZeneca
  7.7.1 AstraZeneca Corporate Summary
  7.7.2 AstraZeneca Business Overview
  7.7.3 AstraZeneca Brain Cancer Treatment Major Product Offerings
  7.7.4 AstraZeneca Brain Cancer Treatment Revenue in Global Market (2017-2022)
  7.7.5 AstraZeneca Key News
7.8 Bristol-Myers Squibb
  7.8.1 Bristol-Myers Squibb Corporate Summary
  7.8.2 Bristol-Myers Squibb Business Overview
  7.8.3 Bristol-Myers Squibb Brain Cancer Treatment Major Product Offerings
  7.8.4 Bristol-Myers Squibb Brain Cancer Treatment Revenue in Global Market (2017-2022)
  7.8.5 Bristol-Myers Squibb Key News
7.9 Amgen Inc
  7.9.1 Amgen Inc Corporate Summary
  7.9.2 Amgen Inc Business Overview
  7.9.3 Amgen Inc Brain Cancer Treatment Major Product Offerings
  7.9.4 Amgen Inc Brain Cancer Treatment Revenue in Global Market (2017-2022)
  7.9.5 Amgen Inc Key News
7.10 GlaxoSmith Kline PLC
  7.10.1 GlaxoSmith Kline PLC Corporate Summary
  7.10.2 GlaxoSmith Kline PLC Business Overview
  7.10.3 GlaxoSmith Kline PLC Brain Cancer Treatment Major Product Offerings
  7.10.4 GlaxoSmith Kline PLC Brain Cancer Treatment Revenue in Global Market (2017-2022)
  7.10.5 GlaxoSmith Kline PLC Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Brain Cancer Treatment Market Opportunities & Trends in Global Market
Table 2. Brain Cancer Treatment Market Drivers in Global Market
Table 3. Brain Cancer Treatment Market Restraints in Global Market
Table 4. Key Players of Brain Cancer Treatment in Global Market
Table 5. Top Brain Cancer Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Brain Cancer Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Brain Cancer Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Brain Cancer Treatment Product Type
Table 9. List of Global Tier 1 Brain Cancer Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Brain Cancer Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Brain Cancer Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Brain Cancer Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Brain Cancer Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Brain Cancer Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Brain Cancer Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Brain Cancer Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Brain Cancer Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Brain Cancer Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Brain Cancer Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Brain Cancer Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Brain Cancer Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Brain Cancer Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Brain Cancer Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Brain Cancer Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Brain Cancer Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Brain Cancer Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Brain Cancer Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Brain Cancer Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Brain Cancer Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Novartis AG Corporate Summary
Table 31. Novartis AG Brain Cancer Treatment Product Offerings
Table 32. Novartis AG Brain Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 33. F. Hoffmann-La Roche Ltd Corporate Summary
Table 34. F. Hoffmann-La Roche Ltd Brain Cancer Treatment Product Offerings
Table 35. F. Hoffmann-La Roche Ltd Brain Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Pfizer,Inc Corporate Summary
Table 37. Pfizer,Inc Brain Cancer Treatment Product Offerings
Table 38. Pfizer,Inc Brain Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Y-mAbs Therapeutics,Inc Corporate Summary
Table 40. Y-mAbs Therapeutics,Inc Brain Cancer Treatment Product Offerings
Table 41. Y-mAbs Therapeutics,Inc Brain Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Merck & Co.Inc Corporate Summary
Table 43. Merck & Co.Inc Brain Cancer Treatment Product Offerings
Table 44. Merck & Co.Inc Brain Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Johnson & Johnson Corporate Summary
Table 46. Johnson & Johnson Brain Cancer Treatment Product Offerings
Table 47. Johnson & Johnson Brain Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 48. AstraZeneca Corporate Summary
Table 49. AstraZeneca Brain Cancer Treatment Product Offerings
Table 50. AstraZeneca Brain Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Bristol-Myers Squibb Corporate Summary
Table 52. Bristol-Myers Squibb Brain Cancer Treatment Product Offerings
Table 53. Bristol-Myers Squibb Brain Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Amgen Inc Corporate Summary
Table 55. Amgen Inc Brain Cancer Treatment Product Offerings
Table 56. Amgen Inc Brain Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 57. GlaxoSmith Kline PLC Corporate Summary
Table 58. GlaxoSmith Kline PLC Brain Cancer Treatment Product Offerings
Table 59. GlaxoSmith Kline PLC Brain Cancer Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Brain Cancer Treatment Segment by Type in 2021
Figure 2. Brain Cancer Treatment Segment by Application in 2021
Figure 3. Global Brain Cancer Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Brain Cancer Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Brain Cancer Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Brain Cancer Treatment Revenue in 2021
Figure 8. By Type - Global Brain Cancer Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Brain Cancer Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Brain Cancer Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Brain Cancer Treatment Revenue Market Share, 2017-2028
Figure 12. US Brain Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Brain Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Brain Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Brain Cancer Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Brain Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Brain Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Brain Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Brain Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Brain Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Brain Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Brain Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Brain Cancer Treatment Revenue Market Share, 2017-2028
Figure 24. China Brain Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Brain Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Brain Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Brain Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Brain Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Brain Cancer Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Brain Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Brain Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Brain Cancer Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Brain Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Brain Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Brain Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Brain Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Novartis AG Brain Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. F. Hoffmann-La Roche Ltd Brain Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Pfizer,Inc Brain Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Y-mAbs Therapeutics,Inc Brain Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Merck & Co.Inc Brain Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Johnson & Johnson Brain Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. AstraZeneca Brain Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Bristol-Myers Squibb Brain Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Amgen Inc Brain Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. GlaxoSmith Kline PLC Brain Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)